tirzepatide wegovy or ozempic So, here's a quick breakdown: Semaglutide (Wegovy/Ozempic) is a GLP-1 receptor agonist — it mimics a gut hormone that regulates appetite and blood sugar. (Zepbound/Mounjaro) is a dual GIP/GLP-1 agonist — Prices of Ozempic vs Mounjaro

They can produce electrolyte shifts

Although the study focused on autoimmune patients with diabetes, the findings highlight the potential of GLP-1 receptor agonists in managing cardiovascular risk in the broader autoimmune population

Safety Monitoring When Combining These Medications The primary safety consideration when using tirzepatide with methotrexate is managing gastrointestinal side effects and ensuring adequate nutrient absorption

[17] [18] Therefore, the combination should not be used with the expectation of enhanced cardiovascular protection

These agents help reduce appetite and delay gastric emptying, leading to reduced food intake useful for people with obesity

When restriction has already been part of the story, adding a medication that suppresses appetite is not a neutral intervention. Gastrointestinal Conditions That Require Caution Because GLP-1 medications slow gastric emptying and affect gut motility, certain GI conditions need special caution